ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Jun 13, 2012
ELITE PHARMACEUTICALS ANNOUNCES BRIDGE LOAN FACILITY
May 22, 2012
ELITE PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT FOR ABUSE RESISTANT ORAL DOSAGE FORMULATION
Mar 22, 2012
ELITE PHARMACEUTICALS SIGNS AN AGREEMENT WITH A PRIVATE HONG KONG-BASED COMPANY TO DEVELOP A PRESCRIPTION PHARMACEUTICAL PRODUCT IN THE US
Mar 13, 2012
ELITE PHARMACEUTICALS ANNOUNCES FIRST SHIPMENT OF GENERIC HYDROMORPHONE PRODUCT
Feb 13, 2012
Elite Pharmaceuticals, Inc. to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012
Jan 26, 2012
ELITE PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL APPLICATION FOR HYDROMORPHONE
Jan 03, 2012
ELITE PHARMACEUTICALS SECURES $5 MILLION FUNDING COMMITMENT
Oct 19, 2011
ELITE PHARMACEUTICALS ANNOUNCES RESULTS OF ANNUAL MEETING OF STOCKHOLDERS
Sep 27, 2011
ELITE PHARMACEUTICALS AND ECR PHARMACEUTICALS LAUNCH LODRANE D® ALLERGY PRODUCT
Aug 16, 2011
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter Ended June 30, 2011
12
13
14
15
16
17
18
19
20
21
22
<<
<
>
>>
Back to top
Privacy
